Review

An update on palliative therapy in advanced prostate cancer

• Kaan Özdedeli
• Uğur Kuyumcuoğlu

Are there any treatment option for metastatic prostate cancer refractory to docetaksel?

• Yaşar Bedük

New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor

• Yavuz Selim Süral
• Çağ Çal

New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate

• Bülent Akdoğan

New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T

• Gürbüz Görümlü
• Erdem Göker

New treatment options in castration resistant prostate cancer: denosumab, alpharadin

• Hakan Gemalmaz

‘Nanotechnology Applications’ in the Treatment of Prostate Cancer

• Ali Furkan Batur
• Kerem Gencer Kutman
• Mustafa Suat Bolat

Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T

• Güven Aslan

New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100

• Sıtkı Ün
• Ferruh Zorlu

Original Articles

The Efficiency of Docetaxel Chemotherapy on Castration Resistant Prostate Cancer: Singe Center Experience

• Evren Süer
• Nurullah Hamidi
• Mehmet İlker Gökçe
• Sümer Baltacı